Keyphrases
Hepatocellular Carcinoma
100%
Single nucleotide Polymorphism
100%
DNA Methyltransferase 3B (DNMT3B)
100%
Moroccan Population
100%
Tumorigenesis
33%
Odds Ratio
33%
Molecular Mechanism
16%
Polymorphism
16%
Mechanistic Studies
16%
DNA Methylation (DNAm)
16%
Genetic Variants
16%
Infected Patients
16%
Healthy Controls
16%
SNP
16%
Adjusted Odds Ratio
16%
Genetic Evidence
16%
Restriction Fragment Length Polymorphism
16%
Promoter Region
16%
Malignant Tumor
16%
T Allele
16%
Hepatocellular Carcinoma Risk
16%
Stratified Analysis
16%
TT Genotype
16%
Oncogenic Role
16%
Medicine and Dentistry
Promoter Region
100%
Single Nucleotide Polymorphism
100%
Hepatocellular Carcinoma
100%
DNA Methyltransferase 3B
100%
Malignant Neoplasm
83%
Odds Ratio
50%
Carcinogenesis
33%
Case-Control Study
16%
Allele
16%
Restriction Fragment Length Polymorphism
16%
DNA Methylation
16%
Polymerase Chain Reaction
16%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Single-Nucleotide Polymorphism
100%
DNA Methyltransferase
100%
Carcinogenesis
33%
Genetics
16%
Case-Control Study
16%
Allele
16%
Genotyping
16%
DNA Methylation
16%
Single Nucleotide Polymorphism
16%
Genetic Divergence
16%
Restriction Fragment Length Polymorphism
16%
Polymerase Chain Reaction
16%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
DNA Methyltransferase 3B
100%
Malignant Neoplasm
83%
Carcinogenesis
33%
Case-Control Study
16%